JP5070046B2 - ストロンチウムおよびビタミンｄを含む組成物およびその使用 - Google Patents

ストロンチウムおよびビタミンｄを含む組成物およびその使用 Download PDF

Info

Publication number
JP5070046B2
JP5070046B2 JP2007516973A JP2007516973A JP5070046B2 JP 5070046 B2 JP5070046 B2 JP 5070046B2 JP 2007516973 A JP2007516973 A JP 2007516973A JP 2007516973 A JP2007516973 A JP 2007516973A JP 5070046 B2 JP5070046 B2 JP 5070046B2
Authority
JP
Japan
Prior art keywords
strontium
composition
calcium
pharmaceutical
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007516973A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008503504A5 (enExample
JP2008503504A (ja
Inventor
ヨン ニコライ バーレ クリステンセン，
Original Assignee
モクワロ エスペーエフ エス．アー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34972075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5070046(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by モクワロ エスペーエフ エス．アー． filed Critical モクワロ エスペーエフ エス．アー．
Publication of JP2008503504A publication Critical patent/JP2008503504A/ja
Publication of JP2008503504A5 publication Critical patent/JP2008503504A5/ja
Application granted granted Critical
Publication of JP5070046B2 publication Critical patent/JP5070046B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2007516973A 2004-06-25 2005-06-24 ストロンチウムおよびビタミンｄを含む組成物およびその使用 Expired - Fee Related JP5070046B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200400991 2004-06-25
DKPA200400991 2004-06-25
DKPA200401733 2004-11-10
DKPA200401733 2004-11-10
PCT/DK2005/000425 WO2006000224A2 (en) 2004-06-25 2005-06-24 Compositions comprising strontium and vitamin d and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012157477A Division JP2012193208A (ja) 2004-06-25 2012-07-13 ストロンチウムおよびビタミンｄを含む組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2008503504A JP2008503504A (ja) 2008-02-07
JP2008503504A5 JP2008503504A5 (enExample) 2008-07-10
JP5070046B2 true JP5070046B2 (ja) 2012-11-07

Family

ID=34972075

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007516973A Expired - Fee Related JP5070046B2 (ja) 2004-06-25 2005-06-24 ストロンチウムおよびビタミンｄを含む組成物およびその使用
JP2012157477A Withdrawn JP2012193208A (ja) 2004-06-25 2012-07-13 ストロンチウムおよびビタミンｄを含む組成物およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012157477A Withdrawn JP2012193208A (ja) 2004-06-25 2012-07-13 ストロンチウムおよびビタミンｄを含む組成物およびその使用

Country Status (15)

Country Link
US (1) US8658206B2 (enExample)
EP (1) EP1768748B2 (enExample)
JP (2) JP5070046B2 (enExample)
KR (1) KR20070034075A (enExample)
AT (1) ATE443541T1 (enExample)
AU (1) AU2005256317B2 (enExample)
BR (1) BRPI0512357A (enExample)
CA (1) CA2571449C (enExample)
DE (1) DE602005016803D1 (enExample)
DK (1) DK1768748T4 (enExample)
EA (1) EA011814B1 (enExample)
IL (1) IL180144A0 (enExample)
MX (1) MXPA06015187A (enExample)
NO (1) NO20070206L (enExample)
WO (1) WO2006000224A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080118603A1 (en) * 2006-11-21 2008-05-22 Lada Mark W Nutritional beverage for optimal bone health
WO2008061535A1 (en) * 2006-11-21 2008-05-29 Strontin Aps Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases.
ES2573327T3 (es) * 2007-04-23 2016-06-07 Baxter International Inc. Composiciones de fibrina que contienen compuestos de estroncio
WO2009010305A2 (en) * 2007-07-19 2009-01-22 Dsm Ip Assets B.V. Tablettable formulations of lipophilic health ingredients
US8790714B2 (en) 2007-08-03 2014-07-29 Nucitec, S.A. De C.V. Compositions and methods for treatment and prevention of osteoarthritis
EP2416756A2 (en) * 2009-04-10 2012-02-15 Mahmut Bilgic Stable pharmaceutical compositions with high bioavailibility
FR2945748A1 (fr) * 2009-05-20 2010-11-26 Debregeas Et Associes Pharma Medicament a base de calcium et de vitamine d.
FR2953139B1 (fr) * 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
EP2591354B1 (en) * 2010-07-07 2016-09-07 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP2590656B1 (en) 2010-07-07 2017-11-15 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
JP5827328B2 (ja) 2010-07-07 2015-12-02 アーデリクス，インコーポレーテッド リン酸輸送を阻害する化合物及び方法
EP2590965B1 (en) 2010-07-07 2016-04-20 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
JP5827326B2 (ja) 2010-07-07 2015-12-02 アーデリクス，インコーポレーテッド リン酸輸送を阻害する化合物及び方法
AU2012212385B2 (en) * 2011-02-02 2015-01-15 Ent Technologies Pty Ltd Compositions and methods for the treatment of nasal passages
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
WO2014044756A1 (en) * 2012-09-20 2014-03-27 Mokwalo SA Strontium as anti microbial compound

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345265A (en) * 1963-10-09 1967-10-03 Kendall & Co Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
US3699221A (en) * 1965-02-23 1972-10-17 Murray L Schole Dental preparations
US3988434A (en) 1972-08-07 1976-10-26 Schole Murray L Dental preparation
FR2633619B1 (fr) 1988-06-29 1991-02-08 Adir Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2651497B1 (fr) 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5380530A (en) 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
FR2749759B1 (fr) 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
CN1164603C (zh) 2001-09-29 2004-09-01 南京化工大学 1，6－二磷酸果糖锶盐系列化合物及其制备方法和在医药中的应用
FR2844797B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt) 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20060216358A1 (en) * 2003-05-07 2006-09-28 Christian Hansen Controlled release composition containing a strontium salt

Also Published As

Publication number Publication date
KR20070034075A (ko) 2007-03-27
EP1768748A2 (en) 2007-04-04
JP2012193208A (ja) 2012-10-11
HK1102427A1 (en) 2007-11-23
DK1768748T4 (da) 2019-06-11
EA011814B1 (ru) 2009-06-30
EP1768748B2 (en) 2019-03-13
CA2571449C (en) 2015-12-08
DK1768748T3 (da) 2010-02-01
US8658206B2 (en) 2014-02-25
US20080026037A1 (en) 2008-01-31
WO2006000224A2 (en) 2006-01-05
CA2571449A1 (en) 2006-01-05
EA200700130A1 (ru) 2007-06-29
BRPI0512357A (pt) 2008-03-04
WO2006000224A3 (en) 2006-05-18
JP2008503504A (ja) 2008-02-07
NO20070206L (no) 2007-03-22
MXPA06015187A (es) 2007-09-27
DE602005016803D1 (de) 2009-11-05
EP1768748B1 (en) 2009-09-23
IL180144A0 (en) 2007-06-03
AU2005256317A1 (en) 2006-01-05
ATE443541T1 (de) 2009-10-15
AU2005256317B2 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
JP2012193208A (ja) ストロンチウムおよびビタミンｄを含む組成物およびその使用
EP2496222B1 (en) The parmaceutical compositions comprising calcium and vitamin d
TW200538054A (en) Multi-vitamin and mineral nutritional supplements
JPH07501343A (ja) 経口用１α−ヒドロキシプレビタミンＤ
CN101309688A (zh) 持续释放β-丙氨酸的组合物和方法
JP2013539768A (ja) 簡単な投与のためのリン酸塩結合剤製剤
WO2010008976A2 (en) Combined calcium, magnesium and vitamin d supplements
WO2010090614A1 (en) Pharmaceutical formulation comprising risedronate, calcium carbonate and vitamin d3 combined in a single dosage form
CA2376017C (en) Potassium calcium citrate compositions and methods for production
JP2002543107A (ja) 葉酸補給物
US6447807B1 (en) Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled delivery
US20170157001A1 (en) Compositions Comprising Strontium and Uses Thereof in the Treatment or Prevention of Gingivitis, Periodontitis, Periodontitis as a Manifestation of Systemic Diseases, and Necrotizing Periodontal Diseases
CN103479582A (zh) 制备含钙组合物的快速湿聚结方法
CN101018586B (zh) 含锶和维生素d的组合物及其用途
US20100331286A1 (en) Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function
JP6513702B2 (ja) 超速崩壊錠剤及びその製造方法
WO2010090613A1 (en) The combined pharmaceutical composition in a single dosage form
WO2015001329A1 (en) Chewable tablet
KR20230151980A (ko) 발포성 약물 제형
US20130172299A1 (en) Combination Therapy for Treatment of Bone and Mineral Disorders for Patients with Impaired Renal Function
HK1102427B (en) Compositions comprising strontium and vitamin d and uses thereof
RU2796676C1 (ru) Водорастворимые таблетки колекальциферола и способ их получения
CN121910679A (zh) 一种包含速释递送组合物和缓释递送组合物的组合及其制备方法和用途
US20090047334A1 (en) Transdermal patch for extended delivery of calcium

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080521

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080521

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110712

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20110729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111012

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20111012

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120314

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120713

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120726

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120814

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120820

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150824

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5070046

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees